Michael Aaron Pratt

Array ( [id] => 7519034 [patent_doc_number] => 07973135 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-05 [patent_title] => 'Compositions and methods for targeting cancer-specific transcription complexes' [patent_app_type] => utility [patent_app_number] => 11/777271 [patent_app_country] => US [patent_app_date] => 2007-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16010 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/973/07973135.pdf [firstpage_image] =>[orig_patent_app_number] => 11777271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4651004 [patent_doc_number] => 20080038260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'ILT3 binding molecules and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/820363 [patent_app_country] => US [patent_app_date] => 2007-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 32738 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20080038260.pdf [firstpage_image] =>[orig_patent_app_number] => 11820363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6576858 [patent_doc_number] => 20100047251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'ANTIBODIES BLOCKING FIBROBLAST GROWTH FACTOR RECEPTOR ACTIVATION AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/304638 [patent_app_country] => US [patent_app_date] => 2007-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13148 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047251.pdf [firstpage_image] =>[orig_patent_app_number] => 12304638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7751991 [patent_doc_number] => 08110654 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-07 [patent_title] => 'T cell epitope peptides of ovarian cancer anti-idiotypic antibody 6B11 and use thereof' [patent_app_type] => utility [patent_app_number] => 12/303244 [patent_app_country] => US [patent_app_date] => 2007-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 8034 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/110/08110654.pdf [firstpage_image] =>[orig_patent_app_number] => 12303244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4948979 [patent_doc_number] => 20080305105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'BISPECIFIC ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 11/754792 [patent_app_country] => US [patent_app_date] => 2007-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6766 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20080305105.pdf [firstpage_image] =>[orig_patent_app_number] => 11754792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4938810 [patent_doc_number] => 20080076129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'Method of Detecting an Increased Susceptibility to Breast Cancer' [patent_app_type] => utility [patent_app_number] => 11/750609 [patent_app_country] => US [patent_app_date] => 2007-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 26538 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076129.pdf [firstpage_image] =>[orig_patent_app_number] => 11750609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4629370 [patent_doc_number] => 08008256 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-30 [patent_title] => 'Combination therapy for treatment of cancer' [patent_app_type] => utility [patent_app_number] => 11/742389 [patent_app_country] => US [patent_app_date] => 2007-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 3 [patent_no_of_words] => 17603 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/008/08008256.pdf [firstpage_image] =>[orig_patent_app_number] => 11742389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4433871 [patent_doc_number] => 07897730 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-01 [patent_title] => 'TRAIL receptor-binding agents and uses of the same' [patent_app_type] => utility [patent_app_number] => 12/298001 [patent_app_country] => US [patent_app_date] => 2007-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 62877 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/897/07897730.pdf [firstpage_image] =>[orig_patent_app_number] => 12298001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4657128 [patent_doc_number] => 20080025989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'ANTI-CD70 ANTIBODY-DRUG CONJUGATES AND THEIR USE FOR THE TREATMENT OF CANCER AND IMMUNE DISORDERS' [patent_app_type] => utility [patent_app_number] => 11/735376 [patent_app_country] => US [patent_app_date] => 2007-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 42508 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20080025989.pdf [firstpage_image] =>[orig_patent_app_number] => 11735376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6431054 [patent_doc_number] => 20100143367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'NOVEL ANTI-CD98 ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/295991 [patent_app_country] => US [patent_app_date] => 2007-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 20916 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143367.pdf [firstpage_image] =>[orig_patent_app_number] => 12295991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5247812 [patent_doc_number] => 20070244046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'IDENTIFICATION AND CHARACTERIZATION OF CANCER STEM CELLS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 11/693691 [patent_app_country] => US [patent_app_date] => 2007-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12050 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20070244046.pdf [firstpage_image] =>[orig_patent_app_number] => 11693691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5091662 [patent_doc_number] => 20070231301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'PARENTERAL LOW DOSE TYPE 1 INTERFERONS FOR BLADDER CANCER' [patent_app_type] => utility [patent_app_number] => 11/692624 [patent_app_country] => US [patent_app_date] => 2007-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6717 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0231/20070231301.pdf [firstpage_image] =>[orig_patent_app_number] => 11692624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6080065 [patent_doc_number] => 20110142824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'Antibodies Against Amyloid-Beta Peptide' [patent_app_type] => utility [patent_app_number] => 12/294438 [patent_app_country] => US [patent_app_date] => 2007-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22137 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20110142824.pdf [firstpage_image] =>[orig_patent_app_number] => 12294438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5091694 [patent_doc_number] => 20070231333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'ANTI-5T4 ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/684329 [patent_app_country] => US [patent_app_date] => 2007-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 30305 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0231/20070231333.pdf [firstpage_image] =>[orig_patent_app_number] => 11684329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4988146 [patent_doc_number] => 20070154485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'ANTICANCER AGENTS USING VEROTOXIN VARIANTS' [patent_app_type] => utility [patent_app_number] => 11/681395 [patent_app_country] => US [patent_app_date] => 2007-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10793 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20070154485.pdf [firstpage_image] =>[orig_patent_app_number] => 11681395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6441268 [patent_doc_number] => 20100104554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'PEPTIDE AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/281356 [patent_app_country] => US [patent_app_date] => 2007-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 13154 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20100104554.pdf [firstpage_image] =>[orig_patent_app_number] => 12281356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5545922 [patent_doc_number] => 20090155799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'METHODS FOR DIAGNOSING PANCREATIC CANCER USING REG4 PROTEIN' [patent_app_type] => utility [patent_app_number] => 12/281206 [patent_app_country] => US [patent_app_date] => 2007-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13457 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155799.pdf [firstpage_image] =>[orig_patent_app_number] => 12281206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5336836 [patent_doc_number] => 20090053300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'MONOCLONAL ANTIBODY, GENE ENCODING THE ANTIBODY, HYBRIDOMA, PHARMACEUTICAL COMPOSITION, AND DIAGNOSTIC REAGENT' [patent_app_type] => utility [patent_app_number] => 12/279160 [patent_app_country] => US [patent_app_date] => 2007-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8839 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20090053300.pdf [firstpage_image] =>[orig_patent_app_number] => 12279160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5247313 [patent_doc_number] => 20070243547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Use of tumor susceptibilty gene 101 (TSG 101) as a prognostic and diagnostic marker' [patent_app_type] => utility [patent_app_number] => 11/706109 [patent_app_country] => US [patent_app_date] => 2007-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12485 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20070243547.pdf [firstpage_image] =>[orig_patent_app_number] => 11706109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5434962 [patent_doc_number] => 20090169548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'BINDING MOLECULES' [patent_app_type] => utility [patent_app_number] => 12/161986 [patent_app_country] => US [patent_app_date] => 2007-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11276 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20090169548.pdf [firstpage_image] =>[orig_patent_app_number] => 12161986 [rel_patent_id] =>[rel_patent_doc_number] =>)